5-MeO-αET
   HOME

TheInfoList



OR:

5-Methoxy-alpha-ethyltryptamine (5-MeO-α-ET) is a
psychoactive drug A psychoactive drug, psychopharmaceutical, psychoactive agent or psychotropic drug is a chemical substance, that changes functions of the nervous system, and results in alterations in perception, mood, consciousness, cognition or behavior. ...
and member of the
tryptamine Tryptamine is an indolamine metabolite of the essential amino acid, tryptophan. The chemical structure is defined by an indole ─ a fused benzene and pyrrole ring, and a 2-aminoethyl group at the second carbon (third aromatic atom, with the f ...
chemical class Chemical classification systems attempt to classify elements or compounds according to certain chemical functional or structural properties. Whereas the structural properties are largely intrinsic, functional properties and the derived classificat ...
. It produces psychedelic and stimulant effects.


Dosage

5-MeO-α-ET, when used recreationally, is usually taken orally at dosages of 50–75 mg.


Effects

5-MeO-α-ET produces entactogenic and stimulant effects that can last 4–6 hours. However, little information exists on the psychopharmacological effects of this compound, thus considerable variation with regard to dosage and effects can be expected.


Dangers

There have been no reported deaths or hospitalizations from 5-MeO-α-ET, but its safety profile is unknown.


Legality

5-MeO-α-ET is unscheduled and uncontrolled in the United States, but possession and sales of 5-MeO-α-ET could be prosecuted under the
Federal Analog Act The Federal Analogue Act, , is a section of the United States Controlled Substances Act passed in 1986 which allows any chemical "substantially similar" to a controlled substance listed in Schedule I or II to be treated as if it were listed in ...
because of its structural similarities to α-ET and α-MT.


See also

* 4-HO-AMT * 4-Methyl-AET * 5-Fluoro-AET * 5-EtO-AMT * 5-MeO-AMT * 7-Methyl-AET * alpha-Ethyltryptamine * alpha-Methyltryptamine


References

{{Tryptamines Psychedelic tryptamines Designer drugs Monoamine oxidase inhibitors Serotonin-norepinephrine-dopamine releasing agents Serotonin receptor agonists Mexamines